SOHO 2020 | Impact of COVID-19 on CAR T-cell therapies

Name: Impact of COVID-19 on CAR T-cell therapies
Uploaded: 2020-09-01T00:00:00Z
Duration: 4 min 23 s
Description: David L. Porter, MD, University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA, explores the impact of the COVID-19 pandemic on the treatment and management of patients with hematological malignancies currently recieving CAR T-cell therapies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

David Porter • 1 Sep 2020

SOHO 2020

General CAR-T

David L. Porter, MD, University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA, explores the impact of the COVID-19 pandemic on the treatment and management of patients with hematological malignancies currently recieving CAR T-cell therapies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).